D
Daxor Corporation DXR
$7.77 $0.26993.60%
Recommendation
Sell
Prev Close
$7.50
Volume
2,621
Avg Vol (90D)
13,934
Market Cap
$36.30M
Dividend & Yield
--
52-Week Range
$6.55 - $10.00
P/E (TTM)
21.22
EPS (TTM)
$0.3534
My Lists My Alerts
Rating
Reward
C-
Fair
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Fair
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Daxor Corporation (DXR) Q4 2024 Earnings Call Transcript
3/7/2025 - Seeking Alpha: Transcripts
Daxor Corporation (DXR) Q4 2024 Earnings Call Transcript
3/7/2025 - SeekingAlpha
Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116. ...
3/4/2025 - GuruFocus
Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024
3/4/2025 - Globe Newswire
Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial ...
3/4/2025 - GuruFocus
Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025
3/4/2025 - Globe Newswire
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ...
3/4/2025 - GuruFocus
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ...
3/4/2025 - GuruFocus
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
3/4/2025 - Globe Newswire
Daxor issues letter to shareholders
3/4/2025 - The Fly
Daxor reports increase in NAV to $7.25 per share
3/4/2025 - TipRanks Financial Blog
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
3/4/2025 - Globe Newswire
Daxor reports increase in NAV to $7.25 per share
3/4/2025 - The Fly
Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116. ...
3/4/2025 - GuruFocus
Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
3/4/2025 - Globe Newswire
Daxor expands BVA services at Midwest healthcare facility
2/28/2025 - The Fly
Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center
2/28/2025 - GuruFocus
Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center
2/28/2025 - Globe Newswire
Daxor expands blood volume analysis technology to New Jersey hospitals
2/27/2025 - The Fly
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals
2/27/2025 - GuruFocus
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals
2/27/2025 - Globe Newswire
Comparing Daxor (NASDAQ:DXR) & iRhythm Technologies (NASDAQ:IRTC)
2/26/2025 - Ticker Report
Daxor reports new studies using Blood Volume Analysis technology
2/19/2025 - The Fly
Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025
2/19/2025 - Globe Newswire
Daxor Co. (NASDAQ:DXR) Short Interest Update
2/19/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
$154.20K
EBITDA (TTM)
--
EBIT (TTM)
-$722.40K
Net Income (TTM)
$1.69M
Balance Sheet
Total Assets (Q)
$34.38M
Total Debt (Q)
$1.65M
Total Liabilities (Q)
$1.72M
Book Value Per Share (Q)
$6.75
Cash Flow
Cash from Operations (TTM)
-$1.68M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$1.68M
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, August 29, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Week of Mar 10 and 14 (est)
Price History
Loading...
Beta
-0.23
7-Day Total Return
5.57%
30-Day Total Return
-4.00%
60-Day Total Return
-14.48%
90-Day Total Return
-13.67%
Year to Date Total Return
2.91%
1-Year Total Return
3.60%
2-Year Total Return
-16.72%
3-Year Total Return
-27.72%
5-Year Total Return
-36.16%
52-week Low
Feb 11, 2025 - $6.55
52-week High
Dec 02, 2024 - $10.00
Valuation
Market Cap
$36.30M - Nano Cap
Enterprise Value
$37.03M
Price/Sales (TTM)
235.85
Price/Book (Q)
1.11
Dividends and Shares
Shares Outstanding
4.84M
Dividend Per Share (Most Recent)
$0.03
Dividend Per Share (TTM)
--
Corporate Info
Website
www.daxor.com
Phone Number
Address
109 Meco Lane
Oak Ridge, TN 37830
Country
United States
Year Founded
1971
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a... more
NASDAQ 03/06/2025 3:54PM Eastern Quotes delayed
Weiss Ratings